cat·a·plex·y

(kăt′ə-plĕk′sē)

n. pl. cat·a·plex·ies

A sudden loss of muscle tone and strength, usually caused by an extreme emotional stimulus.

[From Greek kataplēxis, fixation (of the eyes), from kataplēssein, to astound, terrify : kata-, intensive pref.; see cata- + plēssein, plēk-, to strike; see plāk- in Indo-European roots.]

cat′a·plec′tic (-plĕk′tĭk) adj.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

cataplexy

(ˈkætəˌplɛksɪ)

1. (Pathology) sudden temporary paralysis, brought on by severe shock

2. (Zoology) a state of complete absence of movement assumed by animals while shamming death

[C19: from Greek kataplēxis amazement, from kataplēssein to strike down (with amazement), confound, from kata- down + plēssein to strike]

ˌcataˈplectic adj

Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

cataplexy

a temporary paralytic or hypnotic state, often brought on by strong emotion. — cataplectic, adj.

cat·a·plex·y

n. cataplejía, pérdida repentina del tono muscular causada por un estado emocional intenso.

English-Spanish Medical Dictionary © Farlex 2012

cataplexy

n cataplexia

Mentioned in

nerves

References in periodicals archive

Narcolepsy is a prolonged neurological disorder related to excessive daytime sleepiness (EDS), cataplexy, hypnagogic hallucinations, sleep paralysis, and fragmented night sleep.

Narcolepsy Therapeutics Market Is Projected To Grow Rapidly Owing To Rising Research Activities And Increasing Healthcare Expenditure Till 2025 / Million Insights

'Our top priority is the continued advancement of FT218, our proprietary once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy associated with narcolepsy.

Avadel Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Company Update

(4) Idiopathic hypersomnia is characterized by EDS that occurs in the absence of cataplexy and is accompanied by no more than 1 sleep-onset REM (SOREM) period on an MSLT and the preceding PSG combined.

Hypersomnolence: Unraveling the causes

This disorder is typically characterised by excessive daytime sleepiness and cataplexy (sudden muscle weakness triggered by emotion), among other symptoms.

XW Laboratories Inc passes US FDA orphan drug designation for XWL-008 to treat narcolepsy patients

Using a wheelchair and unable to speak, Charlie lives with brain disorders epilepsy, narcolepsy and cataplexy - all severe conditions in themselves.

Garden dreams for easing health burden; family plan a sensory facility to give joy to daughter

Avadel Pharmaceuticals pic is restructuring to assure funds required to focus on its FT218 clinical program, currently in Phase HI development for the treatment of excessive daytime sleepiness (EDS) and Cataplexy in patients suffering from Narcolepsy.

Avadel Pharma Restructures

Narcolepsy type 1 is a rare disabling sleep disorder mainly characterized by excessive daytime sleepiness and cataplexy, an emotion-triggered sudden loss of muscle tone [1,2].

Intravenous Immunoglobulin Therapy Administered Early after Narcolepsy Type 1 Onset in Three Patients Evaluated by Clinical and Polysomnographic Follow-Up

Cataplexy: The weakening of muscles when you feel strong emotions like embarrassment, laughter, surprise, or anger.

Are you more than tired? 5 symptoms you shouldn't ignore

Xyrem has been the only approved treatment for both excessive daytime sleepiness and cataplexy in patients with narcolepsy.

Generic drug manufacturers keep product pipeline moving

Narcolepsy is characterized by excessive sleepiness, cataplexy, hypnagogic hallucinations, and sleep paralysis during the rapid eye movement period of sleep.

Narcolepsy and cataplexy: a pediatric case report